IDO1 and neoplasm: Mads Hald Andersen and Inge Marie Svane’s studies have found spontaneous IDO1 specific CD4+ and CD8+ T cells in tumor infiltrate and peripheral blood of tumor patients, and identified IDO1 specific HLA-A2-restricted epitopes to induce specific CD8+ T cells that recognize and kill IDO1-positive cells.